
Where the Rubber Meets the Road on AI: Process
A panel discussion in the AI Preconference Forum focused intensively on process
A panel discussion in the AI Preconference Forum focused intensively on process
Cada vez más estados están facilitando que médicos que se formaron en otros países obtengan licencias médicas, un cambio que, según los partidarios, podría aliviar la escasez de doctores en áreas rurales. Los cambios involucran a los programas de residencia: la experiencia práctica y supervisada que los médicos deben completar después de graduarse de la…
At the cybersecurity pre-conference forum, healthcare leaders discuss privacy standards for secure health data
A panel of clinician and other leaders looked at issues around clinician engagement in AI
Industry experts discuss cybersecurity within healthcare organizations at the annual HIMSS conference
UC Davis Health’s chief AI advisor discusses agentic AI and its evolving needs
AbbVie is licensing rights to a drug from Gubra that has encouraging early clinical data in obesity. The once-weekly injectable peptide is a dual agonist of the amylin and calcitonin receptors, both of which play key roles in metabolism. The post AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic…
Liz Cinqueonce, the nonprofit organization’s CEO, discusses the creation of a payer-provider pipeline to ease data sharing to enable value-based care
While it might take another decade for widespread advanced digital surgery, the foundations are being laid today. The post Imagine Advanced Digital Surgery, Anywhere, for Everyone appeared first on MedCity News.
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization. The post Building Service Infrastructure for “Made-To-Order” Therapies appeared first on MedCity News.